Results 111 to 120 of about 1,666 (186)

Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease. [PDF]

Neurol Int
González-Sánchez M, Ramírez-Expósito MJ, Martínez-Martos JM.   +2 more
europepmc   +1 more source

Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset [PDF]

Neurology
Kern J, Böhringer J, Timmann D, Trollmann R, Stendel C, Kamm C, Röbl M, Santhanakumaran V, Groeschel S, Beck-Wödl S, Göricke S, Krägeloh-Mann I, Synofzik M.   +12 more
europepmc   +1 more source

Imaging manifestations in infantile GM1 gangliosidosis: a rare lysosomal storage disorder: a paediatric case report. [PDF]

BJR Case Rep
Bhat S, Sharma S, Bhat S, Kaul A.
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 4 [PDF]

, 1977

core   +1 more source

Brainstem Substructure Atrophy in Late-Onset GM2-Gangliosidosis Imaging Using Automated Segmentation. [PDF]

Cerebellum
Rowe OE, Rangaprakash D, Eichler FS, Schmahmann JD, Barry RL, Stephen CD.   +5 more
europepmc   +1 more source

Innovative Therapeutic Approaches for Improving Patient Life Condition with a Neurological Lysosomal Disease [PDF]

, 2012
Audrey Arfi, Daniel Scherman, Magali Richard   +2 more
core   +2 more sources

Imaging Epilepsy: Past, Passing, and to Come. [PDF]

Epilepsy Curr
Theodore WH, Inati SK, Adler S, Pearl PL, Mcdonald CR.   +4 more
europepmc   +1 more source

Tourette syndrome: effects of acetyl-leucine in two individuals. [PDF]

J Neurol
Hofer EM, Musil R, Strupp L, Falkai P, Strupp M, Schindlbeck KA.   +5 more
europepmc   +1 more source

Development of an Infantile GM2 Clinical Rating Scale: Remote Assessment of Clinically Meaningful Health-Related Function. [PDF]

J Child Neurol
Kiefer M, Simione M, Eichler FS, Townsend EL.   +3 more
europepmc   +1 more source

Generalized Gangliosidoses [PDF]

, 2019
openaire   +1 more source